Volume 4 Number 4

Website Exclusive Contents!
Exclusive contents: images and/or videos
Editorial
71
PUBMED/MEDLINE indexing

EuroInterv.2009;4:413

72
The gender paradox

EuroInterv.2009;4:415-417

73
Observational studies of drug-eluting stents – some are more equal than others.

EuroInterv.2009;4:419-423

EAPCI column
74
As time goes on... reflections. A greeting and ongoing wish-list from your EAPCI

EuroInterv.2009;4:425-426

Focus article
75
Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007

EuroInterv.2009;4:427-436

Clinical research
76
Effect of percutaneous mitral repair with the MitraClip® device on mitral valve area and gradient

EuroInterv.2009;4:437-442

77
Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial.

EuroInterv.2009;4:443-448

78
Twelve month clinical and angiographic outcome after stenting of unprotected left main coronary artery stenosis with paclitaxel-eluting stents – results of the multicentre FRIEND registry

EuroInterv.2009;4:449-456

79
Long-term follow-up of percutaneous coronary intervention of unprotected left main lesions with drug eluting stents: predictors of clinical outcome

EuroInterv.2009;4:457-463

80
The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n=6129)

EuroInterv.2009;4:464-474

81
Dual quantitative coronary angiography: a novel approach to quantify intracoronary thrombotic burden

EuroInterv.2009;4:475-480

82
Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents

EuroInterv.2009;4:481-484

83
Predictors for very late stent thrombosis after drug-eluting stent implantation in diabetic patients

EuroInterv.2009;4:485-491

84
Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS I and ARTS II

EuroInterv.2009;4:492-501

85
Clinical investigation into the observation that silicon carbide coating on cobalt chromium stents leads to early differentiating functional endothelial layer, increased safety and DES-like recurrent stenosis rates: results of the PRO-Heal Registry (PRO-Kinetic enhancing rapid in-stent endothelialisation)

EuroInterv.2009;4:502-508

86
Integration of 3D reconstruction in the SELection criteria for Excessive Crossing Times for Magnetically Supported Percutaneous Coronary Intervention. SELECT-MP

EuroInterv.2009;4:509-516

87
Magnetically navigated percutaneous coronary intervention in distal and/or complex lesions may improve procedural outcome and material consumption

EuroInterv.2009;4:517-523

88
Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention

EuroInterv.2009;4:524-528

Expert review
89
Current and future developments in intracoronary optical coherence tomography imaging

EuroInterv.2009;4:529-534

Experimental research
90
In vivo evaluation of a biolimus eluting nickel titanium self expanding stent with overlapping balloon expandable drug eluting and bare metal stents in a porcine coronary model

EuroInterv.2009;4:534-541

How should I treat?
91
Coronary steal with unstable angina secondary to a coronary artery fistula This article contains pictures and/or videos

EuroInterv.2009;4:542-548

Volume 4 Number 4 has been released thanks to the support of the following partners:
  • Abbott Vascular Devices
  • Biotronik AG
  • Cordis, a Johnson & Johnson company
  • Hexacath
  • Medtronic
  • Terumo

Online ISSN 1969-6213 - Print ISSN 1774-024X